ORLANDO, ROCCO
 Distribuzione geografica
Continente #
NA - Nord America 6.899
EU - Europa 1.140
AS - Asia 773
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 8.843
Nazione #
US - Stati Uniti d'America 6.893
CN - Cina 485
FI - Finlandia 281
DE - Germania 203
IT - Italia 197
SE - Svezia 182
SG - Singapore 178
UA - Ucraina 160
VN - Vietnam 76
GB - Regno Unito 61
IE - Irlanda 16
PE - Perù 16
NL - Olanda 14
TR - Turchia 10
PK - Pakistan 9
FR - Francia 7
CA - Canada 6
IN - India 6
EU - Europa 5
RO - Romania 4
BO - Bolivia 3
BY - Bielorussia 3
AU - Australia 2
BD - Bangladesh 2
HR - Croazia 2
IR - Iran 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
Totale 8.843
Città #
Fairfield 866
Woodbridge 836
Ann Arbor 679
Jacksonville 584
Chandler 522
Houston 507
Wilmington 410
Ashburn 405
Cambridge 283
Princeton 267
Seattle 246
Roxbury 174
Medford 134
Nanjing 128
San Diego 109
Singapore 107
Beijing 95
Helsinki 91
Dong Ket 76
Boardman 66
Des Moines 61
Padova 50
Shenyang 46
Hebei 37
Nanchang 37
New York 35
Norwalk 35
Jiaxing 29
Changsha 26
Guangzhou 25
Tianjin 25
Washington 18
Redwood City 17
Dublin 14
London 12
Greifswald 10
Jinan 10
Rome 10
Kharkiv 9
Milan 9
Rawalpindi 9
Saarbrücken 9
Yenibosna 9
Kilburn 8
Martellago 7
Ogden 7
Tingo Maria 7
Borås 6
Detroit 6
Treviso 6
Utrecht 6
Arequipa 5
Indiana 5
Taizhou 5
Cividale del Friuli 4
Hounslow 4
Lima region 4
Rende 4
Tappahannock 4
Chicago 3
Cochabamba 3
Dearborn 3
Haikou 3
Hangzhou 3
Rockville 3
Salihorsk 3
Toronto 3
Andover 2
Buffalo 2
Caselle Torinese 2
Chiswick 2
Ginosa 2
Kiel 2
Marano Di Napoli 2
Moscow 2
New Bedfont 2
Ningbo 2
Nocera Superiore 2
Nürnberg 2
Perugia 2
Phoenix 2
Radomsko 2
Sorga 2
Taiyuan 2
Tehran 2
Varese 2
Verona 2
Vigliano Biellese 2
Wandsworth 2
Acton 1
Alghero 1
Amsterdam 1
Auburn Hills 1
Auckland 1
Aversa 1
Benevento 1
Brescia 1
Bridgeport 1
Bronte 1
Busalla 1
Totale 7.294
Nome #
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 132
Bone mineral density and bone remodelling markers osteocalcin and alkaline phosphatase in patients with Stage IV breast cancer 131
Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype 127
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 123
Relationship between serum N-telopeptide and bone alkaline phosphatase and their diagnostic value in patients with breast cancer and bone metastases 114
Effect of liver cirrhosis on phenylalanine and tyrosine metabolism 106
Epidemiology of unconjugated hyperbilirubinemia revisited 105
Effect of CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function 103
Komplikationen der internistischen Laparoskopie. 101
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 98
A modeling study of the effect of fasting on bilirubin kinetics in Gilbert's syndrome 98
Associazione tra gruppi sanguigni ABO, colelitiasi e sindrome di Gilbert 98
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis 97
Bile acid treatment of cholesterol gallstones: a reappraisal. 96
The effect of liver disease on inhibitory and plasma protein-binding displacement interaction:an update. 95
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 94
Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. 93
Macro-aspartate aminotransferase ("Macro-AST"). A 12-year follow-up study in a young female 92
A reassessment of the optimal sampling time for the MEGX liver function test 91
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis 89
Colorectal cancer laboratory screening using a multiplex immunoassay based on automated protein-array system for tumor markers 86
Hepatitis C virus infection:sexual or non-sexual transmission between spouses? A case report and review of the Literature. 86
Congenital anomalies of the liver: laparoscopic observations 85
Clinical significance of serum bilirubins:recent advances. 85
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis 82
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis 78
Irreversible CYP3A Inhibition Accompained by Plasma Protein-Binding Displacement: A Comparative Analysis in Subjects with normal and impaired liver function. 77
Effect of gender on the monoethylglycinexylidide test in healthy subjects and patients with liver cirrhosis 77
Bile leakage and resultant bile peritonitis during or after diagnostic laparoscopy:an unpredictable event. 74
An evaluation of bilirubin kinetics with respect to the diagnosis of Gilbert's syndrome. 74
Are liver cirrhosis and portal hypertension associated with an increased risk of bleeding during laparoscopy? A retrospective analysis of 1000 consecutive cases. 73
Sindrome di Gilbert. Nuove acquisizioni della clinica, della diagnostica ed orientamenti terapeutici. 73
Smooth liver surface may conceal cirrhosis. Evidence for the late development of nodular surface of the cirrhotic liver. 73
Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers 72
Influence of rifamycin SV on bile acid metabolism in rats. 72
Effetto del glucosio e dell'uridin-difosfoglucosio (UDPG) sulla iperbilirubinemia da dogiuno nella sindrome di Gilbert. 72
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure 72
Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. 72
The effect of drugs on bile flow and composition. An overview 72
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. 71
The epidemiology of hepatitis delta infection in Italy 71
Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis. 70
Effects of chronic renal failure and hemodialysis on the monoethylglycinexylidide liver function test. 70
Laparoscopy and guided liver biopsy in the diagnosis of cirrhosis: conventional technique vs minilaparoscopy 69
Relationship between Bone Formation Markers Bone Alkaline Phosphatase, Osteocalcin and Amino-terminal Propeptide of Type I Collagen and Bone Mineral Density in Elderly Men. Preliminary Results. 69
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 69
Laparoscopy in chronic renal failure. 69
Antipyrine clearance: evaluation of simplified methods in chronic liver diseases. 69
Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications? 66
Paravaterian diverticula presenting as acute cholangitis in two very elderly patients. 65
Effect of renal flailure on metabolic disposition of lidocaine in patients undergoing and not undergoing hemodialysis 65
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 65
Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis. 65
Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion. 65
Gastrohepatopleural fistula complicating a gastric diverticulum: A rare event and a difficult diagnosis. 64
Automated protein-array chip system for bone turnover markers measurement in pre- and postmenopausal women with osteoporosis 59
Effect of Silybin on biliary lipid composition in rats. 59
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. (Protocol) 58
Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis 58
A comparative study of a silybin-phosphatidilcholine complex and Silymarin. 56
Simultaneous multianalyte immunoassay measurement of five serum tumor markers in the detection of colorectal cancer. 56
Validity of laparoscopy after abdominal surgery. 56
Complications of laparoscopy in the elderly: a report on 345 consecutive cases and comparison with a younger population. 55
The lipoprotein composition of plasma and ascitic fluid in liver cirrhosis. 55
Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. (Protocol) 54
Pharmacokinetics of miocamycin in patients with liver cirrhosis. 54
La sindrome dell'intestino corto: fisiopatologia, clinica ed orientamenti terapeutici 54
Evaluation ciprofloxacin and ofloxacin pharmacokinetics in liver cirrhosis. 54
Cytokines, thyroid disease and thyroid cancer 54
Leucine and phenylalanine kinetics in compensated liver cirrhosis: effects of insulin. 53
Adrenocortical carcinoma: a 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis 52
EFFECT OF SILIBININ ON BILIARY LIPID-COMPOSITION - EXPERIMENTAL AND CLINICAL-STUDY 52
Can intestinal trocar injuries during laparoscopy be really avoided? Report upon a case. 51
Alcuni aspetti del metabolismo glicidico in corso di epatite acuta. 51
Development of mantle cell lymphoma in a patient with adrenocortical carcinoma and an 18-year survival after complete removal of the primary cancer and resection of local recurrences 50
Macro-aspartate aminotransferase and pregnancy: any influence? 49
Recurrent dermatofibrosarcoma protuberans sixteen years after radical excision. A case report 49
Effects of chronic renal failure and haemodynamic therapy on the monoethylglycinexylidide (MEGX) liver function test 47
Fluvoxamine pharmacokinetics in elderly subjects and patients with chronic heart failure 47
DELAYED RECOGNITION OF INADVERTENT GUT INJURY DURING LAPAROSCOPY. 47
The perihepatic adipose tissue thichness: a non-invasive marker of NAFLD? 46
AGENESIS OF THE GALLBLADDER ASSOCIATED WITH GILBERT'S SYNDROME. A THIRTY-YEAR FOLLOW-UP STUDY. 45
Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis 44
Congenital anomalies of the spleen mimiking hematological disorders and solid tumors: a single-center experience of 2650 consecutive diagnostic laparoscopies 43
Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses. 43
Pharmacokinetic of rokitamycin after single and repeated oral administration to partients with liver cirrhosis 42
A simplified procedure for the determination of bilirubin kinetics in humans: a test for the diagnosis of Gilbert's syndrome. 41
Pharmacokinetics studies in liver cirrhosis. 40
Laparoscopy today 40
Emocromatosi e morbo di Wilson 39
Late liver metastases of choroidal melanoma detected by laparoscopy 39
Risk factors incidence in postmenopausal women with hormone receptor negative/HER2 positive and triple negative breast cancer. Preliminary results 38
BSP vs bilirubin kinetics in Gilbert's syndrome. 38
An evaluation of the ability of the bilirubin and bromosulphthalein tests in discriminating patients with unconjugated hyperbilirubinemia. 38
Farmacocinetica delal ranitidina in pazienti affetti da cirrosi epatica. 38
Evaluation of prognostic factors of medical dissolution of cholesterol gallstones using Cox's multivariate regression model. 37
Aspetti metabolici in corso di porfiria cutanea tarda: effetti della dieta e del trattamento con UDPG. 37
Pharmacokinetic studies in liver cirrhosis. Further advances 37
BLADDER INJURY DURING DIAGNOSTIC LAPAROSCOPY. A CASE REPORT. 36
Nuove acquisizioni sulla patogenesi e terapia dell'encefalopatia porto-sistemica. 36
Totale 6.747
Categoria #
all - tutte 27.797
article - articoli 22.643
book - libri 247
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.190
Totale 54.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.555 384 40 30 108 146 111 105 149 145 166 79 92
2020/2021962 33 82 17 80 37 129 32 102 139 68 114 129
2021/20221.714 28 297 118 170 76 65 45 173 53 25 124 540
2022/20231.261 332 108 12 101 230 176 3 76 129 14 55 25
2023/2024662 32 63 81 37 62 122 11 20 18 3 106 107
Totale 8.891